TiGenix, Takeda in Cx601 deal

TiGenix N.V. (Euronext:TIG) rose EUR 0.22 (24%) to EUR 1.12 on Tuesday after it granted Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) exclusive ex-U.S.

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE